Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0384 | 0.3391 | 1 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0134 | 0.0693 | 0.2043 |
Echinococcus granulosus | GPCR family 2 | 0.015 | 0.0867 | 0.2557 |
Plasmodium vivax | hypothetical protein, conserved | 0.007 | 0 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.015 | 0.0867 | 0.2557 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0362 | 0.316 | 0.9319 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0475 | 0.4377 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0352 | 0.3053 | 0.9005 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.007 | 0 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0384 | 0.3391 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0352 | 0.3053 | 0.6976 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0352 | 0.3053 | 0.6976 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.015 | 0.0867 | 0.1981 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0384 | 0.3391 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.015 | 0.0867 | 0.2557 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0134 | 0.0693 | 0.7501 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0384 | 0.3391 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0475 | 0.4377 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0362 | 0.316 | 0.9319 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.007 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.007 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0384 | 0.3391 | 0.7747 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0925 | 0.9242 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0352 | 0.3053 | 0.9005 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0384 | 0.3391 | 1 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0134 | 0.0693 | 0.2043 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Loa Loa (eye worm) | hypothetical protein | 0.0475 | 0.4377 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0257 | 0.2018 | 0.461 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.007 | 0 | 0.5 |
Brugia malayi | RNA binding protein | 0.0352 | 0.3053 | 0.6976 |
Schistosoma mansoni | copper/topaquinone oxidase | 0.0286 | 0.2336 | 0.6888 |
Brugia malayi | TAR-binding protein | 0.0352 | 0.3053 | 0.6976 |
Brugia malayi | kinase, mitochondrial precursor | 0.0384 | 0.3391 | 0.7747 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.007 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.015 | 0.0867 | 0.2557 |
Echinococcus granulosus | amiloride sensitive amine oxidase | 0.0286 | 0.2336 | 0.6888 |
Onchocerca volvulus | 0.007 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0325 | 0.2752 | 0.6288 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.015 | 0.0867 | 0.2557 |
Schistosoma mansoni | hypothetical protein | 0.0286 | 0.2336 | 0.6888 |
Echinococcus multilocularis | amiloride sensitive amine oxidase | 0.0286 | 0.2336 | 0.6888 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0384 | 0.3391 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0352 | 0.3053 | 0.6976 |
Plasmodium vivax | hypothetical protein, conserved | 0.007 | 0 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.015 | 0.0867 | 0.1981 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.015 | 0.0867 | 0.2557 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.0867 | 0.1981 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.007 | 0 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0257 | 0.2018 | 0.461 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0325 | 0.2752 | 0.6288 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0995 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Schistosoma mansoni | hypothetical protein | 0.0325 | 0.2752 | 0.8117 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.007 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0257 | 0.2018 | 0.461 |
Loa Loa (eye worm) | TAR-binding protein | 0.0352 | 0.3053 | 0.6976 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0384 | 0.3391 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0475 | 0.4377 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.015 | 0.0867 | 0.1981 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0155 | 0.0923 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Toxoplasma gondii | hypothetical protein | 0.0145 | 0.0805 | 0.8717 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.